Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
Hong Kong · Delayed Price · Currency is HKD 0.3600
+0.0200 (5.88%)
Oct 30, 2026, 4:08 PM HKT
HKG:0897 Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 683.44 | 683.44 | 745.3 | 783.88 | 723.6 | 1,391 |
Revenue Growth | -5.24% | -8.30% | -4.92% | 8.33% | -47.99% | 25.52% |
Gross Profit Gross Profit Growth | 361.93 | 361.93 | 376.45 | 394.81 | 342.36 | 574.15 |
Operating Income Operating Income Growth | -15.89 | -15.89 | -46.91 | 40.88 | 4.99 | 69.58 |
Net Income Net Income Growth | 3.99 | 3.99 | 7.1 | -15.36 | -20.52 | -108.91 |
Earnings Per Share EPS Growth | 0.00 | 0.00 | 0.01 | -0.01 | -0.02 | -0.09 |
EPS Growth | - | -43.74% | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Chinese Pharmaceutical Chinese Pharmaceutical Growth | 607.17 | 607.17 | 651.71 | 690.6 | 636.43 | 512.61 |
Western Pharmaceutical Western Pharmaceutical Growth | 74.03 | 74.03 | 91.57 | 90.21 | 83.13 | 43.09 |
Property Investment Property Investment Growth | 6.47 | 6.47 | 9.17 | 18.79 | 21.67 | 20.18 |
Eliminations Eliminations Growth | -4.22 | -4.22 | -7.15 | -15.72 | -17.63 | -14.94 |
Total Total Growth | 683.44 | 683.44 | 745.3 | 783.88 | 723.6 | 1,391 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 143.49 | 143.49 | 142.7 | 191.85 | 568.44 | 629.74 |
Total Debt Total Debt Growth | 337.95 | 337.95 | 435.41 | 560.07 | 1,765 | 1,804 |
Net Cash (Debt) Net Cash Growth | -194.46 | -194.46 | -292.71 | -368.22 | -1,196 | -1,174 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.17 | -0.17 | -0.26 | -0.31 | -0.98 | -0.95 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 70.43 | 70.43 | 102.32 | 191.69 | 168.34 | 169.11 |
Capital Expenditures CapEx Growth | -13.49 | -13.49 | -27.16 | -34.65 | -33.45 | -26.04 |
Free Cash Flow Free Cash Flow Growth | 56.94 | 56.94 | 75.16 | 157.04 | 134.89 | 143.07 |
Free Cash Flow Growth | -32.13% | -24.24% | -52.14% | 16.42% | -5.72% | -59.48% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 52.96% | 52.96% | 50.51% | 50.37% | 47.31% | 41.26% |
Operating Margin | -2.33% | -2.33% | -6.29% | 5.21% | 0.69% | 5.00% |
Pretax Margin | 0.53% | 0.53% | 0.55% | -1.74% | -0.82% | -3.40% |
Profit Margin | 0.58% | 0.58% | 0.95% | -1.96% | -2.83% | -7.83% |
FCF Margin | 8.33% | 8.33% | 10.08% | 20.03% | 18.64% | 10.28% |
Fiscal Year | FY 2024 |
|---|---|
| Period Ending | Mar '24 Mar 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.030 |
Dividend Per Share Growth | - |
Dividend Yield | 12.29% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 101.47 | 92.12 | 57.05 | - | - | - |
P/FCF Ratio | 7.05 | 6.46 | 5.39 | 1.82 | 3.22 | 2.50 |
PS Ratio | 0.59 | 0.54 | 0.54 | 0.37 | 0.60 | 0.26 |